All In Biotech

Free tool

FAERS Monitor: Apidra Solostar

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 021629 or its brand name (Apidra Solostar, Insulin Glulisine Recombinant). Reports on generic versions are filed under their own applications.

Reports

10,207

Serious

7,737

76% of reports

Hospitalization

4,127

Death reported

819

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased1,577
  • hypoglycaemia785
  • hyperglycaemia655
  • drug ineffective582
  • blood glucose decreased455
  • dizziness407
  • malaise398
  • dyspnoea393
  • nausea380
  • vomiting348
  • acute kidney injury310
  • fatigue310
  • asthenia305
  • diarrhoea294
  • diabetes mellitus inadequate control286

Reports by year received

View as table
YearReports
20059
200673
2007187
2008119
2009197
2010291
2011480
2012513
2013578
2014867
20151,076
2016615
2017613
2018968
2019869
2020576
2021428
2022470
2023384
2024345
2025295
2026254

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,952 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hyperglycaemiaSignal65537.735.022,985
hypoglycaemiaSignal78533.931.724,670
diabetes mellitus inadequate controlSignal28633.830.18,938
blood glucose decreasedSignal45519.718.08,001
blood glucose increasedSignal1,57717.416.624,351
acute kidney injurySignal3104.23.7751
malaise3981.91.7164
dizziness4071.71.5115
asthenia3051.71.583
vomiting3481.51.464
dyspnoea3931.41.352
nausea3801.00.90
diarrhoea2940.90.81
drug ineffective5820.90.85
fatigue3100.80.712

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.